Istituto Nazionale Tumori IRCCS Fondazione Giovanni Pascale

Naples 80131

0 studies enrolling now · 3 studies all time

What they study most

Melanoma, Neoplasm Metastasis, Non-small Cell Lung Cancer

Studies at this site

• Study of PF-07265807 in Participants With Metastatic Solid Tumors. — Stopped early
• An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer — Completed
• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed